Advances in the non-invasive assessment of vascular dysfunction in metabolic syndrome and diabetes: Focus on endothelium, carotid mechanics and renal vessels

Nutrition, Metabolism and Cardiovascular Diseases

Volumn 27, Issue 2, 2017, Pages 121-128

  Bruno, R M ^a   Reesink, K D ^b,c   Ghiadoni, L ^a  

^a UNIVERSITY OF PISA   (Italy)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Arterial stiffness; Biomechanics; Carotid artery; Endothelium; Flow mediated dilation; Nephropathy; Renal blood flow; Wall stress

Indexed keywords

COLLAGEN; ELASTIN;

ARTERIAL STIFFNESS; ARTERY COMPLIANCE; ARTICLE; CALCIFICATION; CAROTID ARTERY; DIABETIC NEPHROPATHY; ECHOGRAPHY; ENDOTHELIAL DYSFUNCTION; EXTRACELLULAR MATRIX; GLUCOSE METABOLISM; GLYCATION; HUMAN; KIDNEY BLOOD FLOW; KIDNEY BLOOD VESSEL; META ANALYSIS (TOPIC); METABOLIC SYNDROME X; MICROCIRCULATION; NON INSULIN DEPENDENT DIABETES MELLITUS; NON INVASIVE PROCEDURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PREDICTIVE VALUE; PRIORITY JOURNAL; RENOVASCULAR DISEASE; SMOOTH MUSCLE CELL; VASCULAR DISEASE; ANIMAL; CARDIOVASCULAR SYSTEM EXAMINATION; CAROTID ARTERY DISEASES; COMPLICATION; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; EARLY DIAGNOSIS; HEMODYNAMICS; KIDNEY; META ANALYSIS; PATHOPHYSIOLOGY; PROGNOSIS; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; CAROTID ARTERIES; CAROTID ARTERY DISEASES; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIAGNOSTIC TECHNIQUES, CARDIOVASCULAR; EARLY DIAGNOSIS; ENDOTHELIUM, VASCULAR; HEMODYNAMICS; HUMANS; KIDNEY; METABOLIC SYNDROME X; PREDICTIVE VALUE OF TESTS; PROGNOSIS;

EID: 85006115551     PISSN: 09394753     EISSN: 15903729     Source Type: Journal    
DOI: 10.1016/j.numecd.2016.09.004     Document Type: Article

References (85)

1. [1] Ng, M., Fleming, T., Robinson, M., Thomson, B., Graetz, N., Margono, C., et al. Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013. Lancet 384 (2014), 766–781.
2. [2] Stehouwer, C.D., Henry, R.M., Ferreira, I., Arterial stiffness in diabetes and the metabolic syndrome: a pathway to cardiovascular disease. Diabetologia 51 (2008), 527–539.
3. [3] Henry, R.M., Ferreira, I., Kostense, P.J., Dekker, J.M., Nijpels, G., Heine, R.J., et al. Type 2 diabetes is associated with impaired endothelium-dependent, flow-mediated dilation, but impaired glucose metabolism is not; the Hoorn Study. Atherosclerosis 174 (2004), 49–56.
4. [4] Ghiadoni, L., Faita, F., Salvetti, M., Cordiano, C., Biggi, A., Puato, M., et al. Assessment of flow-mediated dilation reproducibility: a nationwide multicenter study. J Hypertens 30 (2012), 1399–1405.
5. [5] Matsuzawa, Y., Kwon, T.G., Lennon, R.J., Lerman, L.O., Lerman, A., Prognostic value of flow-mediated vasodilation in brachial artery and fingertip artery for cardiovascular events: a systematic review and meta-analysis. J Am Heart Assoc, 4, 2015.
6. [6] van Bussel, F.C., van Bussel, B.C., Hoeks, A.P., Op 't Roodt, J., Henry, R.M., Ferreira, I., et al. A control systems approach to quantify wall shear stress normalization by flow-mediated dilation in the brachial artery. PloS one, 10, 2015, e0115977.
7. [7] Joannides, R., Haefeli, W.E., Linder, L., Richard, V., Bakkali, E.H., Thuillez, C., et al. Nitric oxide is responsible for flow-dependent dilatation of human peripheral conduit arteries in vivo. Circulation 91 (1995), 1314–1319.
8. [8] Ghiadoni, L., Versari, D., Magagna, A., Kardasz, I., Plantinga, Y., Giannarelli, C., et al. Ramipril dose-dependently increases nitric oxide availability in the radial artery of essential hypertension patients. J Hypertens 25 (2007), 361–366.
9. [9] Bruno, R.M., Bianchini, E., Faita, F., Taddei, S., Ghiadoni, L., Intima media thickness, pulse wave velocity, and flow mediated dilation. Cardiovasc Ultrasound, 12, 2014, 34.
10. [10] Charakida, M., de Groot, E., Loukogeorgakis, S.P., Khan, T., Luscher, T., Kastelein, J.J., et al. Variability and reproducibility of flow-mediated dilatation in a multicentre clinical trial. Eur heart J 34 (2013), 3501–3507.
11. [11] Gemignani, V., Faita, F., Ghiadoni, L., Poggianti, E., Demi, M., A system for real-time measurement of the brachial artery diameter in B-mode ultrasound images. IEEE Trans Med Imaging 26 (2007), 393–404.
12. [12] Ghiadoni, L., Penno, G., Giannarelli, C., Plantinga, Y., Bernardini, M., Pucci, L., et al. Metabolic syndrome and vascular alterations in normotensive subjects at risk of diabetes mellitus. Hypertension 51 (2008), 440–445.
13. [13] Lteif, A.A., Han, K., Mather, K.J., Obesity, insulin resistance, and the metabolic syndrome: determinants of endothelial dysfunction in whites and blacks. Circulation 112 (2005), 32–38.
14. [14] Plantinga, Y., Ghiadoni, L., Magagna, A., Giannarelli, C., Penno, G., Pucci, L., et al. Peripheral wave reflection and endothelial function in untreated essential hypertensive patients with and without the metabolic syndrome. J Hypertens 26 (2008), 1216–1222.
15. [15] Montero, D., Walther, G., Perez-Martin, A., Vicente-Salar, N., Roche, E., Vinet, A., Vascular smooth muscle function in type 2 diabetes mellitus: a systematic review and meta-analysis. Diabetologia 56 (2013), 2122–2133.
16. [16] Bruno, R.M., Penno, G., Daniele, G., Pucci, L., Lucchesi, D., Stea, F., et al. Type 2 diabetes mellitus worsens arterial stiffness in hypertensive patients through endothelial dysfunction. Diabetologia 55 (2012), 1847–1855.
17. [17] Thacher, T., Gambillara, V., Da Silva, R., Montorzi, G., Stergiopulos, N., Silacci, P., Oscillatory shear stress and reduced compliance impair vascular functions. Clin Hemorheol Microcirc 37 (2007), 121–130.
18. [18] Picchi, A., Capobianco, S., Qiu, T., Focardi, M., Zou, X., Cao, J.M., et al. Coronary microvascular dysfunction in diabetes mellitus: a review. World J Cardiol 2 (2010), 377–390.
19. [19] Flammer, A.J., Anderson, T., Celermajer, D.S., Creager, M.A., Deanfield, J., Ganz, P., et al. The assessment of endothelial function: from research into clinical practice. Circulation 126 (2012), 753–767.
20. [20] De Boer, M.P., Meijer, R.I., Wijnstok, N.J., Jonk, A.M., Houben, A.J., Stehouwer, C.D., et al. Microvascular dysfunction: a potential mechanism in the pathogenesis of obesity-associated insulin resistance and hypertension. Microcirculation 19 (2012), 5–18.
21. [21] Bruno, R.M., Taddei, S., New-onset diabetes in hypertensive patients and mortality: timing is everything. Eur heart J 37 (2016), 975–977.
22. [22] Bruno, R.M., Gori, T., Ghiadoni, L., Endothelial function testing and cardiovascular disease: focus on peripheral arterial tonometry. Vasc health risk Manag 10 (2014), 577–584.
23. [23] Hamburg, N.M., Palmisano, J., Larson, M.G., Sullivan, L.M., Lehman, B.T., Vasan, R.S., et al. Relation of brachial and digital measures of vascular function in the community: the Framingham heart study. Hypertension 57 (2011), 390–396.
24. [24] Schnabel, R.B., Schulz, A., Wild, P.S., Sinning, C.R., Wilde, S., Eleftheriadis, M., et al. Noninvasive vascular function measurement in the community: cross-sectional relations and comparison of methods. Circ Cardiovasc Imaging 4 (2011), 371–380.
25. [25] Mahe, G., Humeau-Heurtier, A., Durand, S., Leftheriotis, G., Abraham, P., Assessment of skin microvascular function and dysfunction with laser speckle contrast imaging. Circ Cardiovasc Imaging 5 (2012), 155–163.
26. [26] Kashyap, V.S., Lakin, R.O., Feiten, L.E., Bishop, P.D., Sarac, T.P., In vivo assessment of endothelial function in human lower extremity arteries. J Vasc Surg 58 (2013), 1259–1266.
27. [27] Thijssen, D.H., Rowley, N., Padilla, J., Simmons, G.H., Laughlin, M.H., Whyte, G., et al. Relationship between upper and lower limb conduit artery vasodilator function in humans. J Appl Physiol 2011:111 (1985), 244–250.
28. [28] Schofield, I., Malik, R., Izzard, A., Austin, C., Heagerty, A., Vascular structural and functional changes in type 2 diabetes mellitus: evidence for the roles of abnormal myogenic responsiveness and dyslipidemia. Circulation 106 (2002), 3037–3043.
29. [29] Bruno, R.M., Ghiadoni, L., Vascular smooth muscle function: defining the diabetic vascular phenotype. Diabetologia 56 (2013), 2107–2109.
30. [30] Laurent, S., Cockcroft, J., Van Bortel, L., Boutouyrie, P., Giannattasio, C., Hayoz, D., et al. Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur Heart J 27 (2006), 2588–2605.
31. [31] Townsend, R.R., Wilkinson, I.B., Schiffrin, E.L., Avolio, A.P., Chirinos, J.A., Cockcroft, J.R., et al. Recommendations for improving and standardizing vascular research on arterial stiffness: a scientific statement from the American Heart Association. Hypertension 66 (2015), 698–722.
32. [32] Hoeks, A.P., Brands, P.J., Smeets, F.A., Reneman, R.S., Assessment of the distensibility of superficial arteries. Ultrasound Med Biol 16 (1990), 121–128.
33. [33] Reneman, R.S., Meinders, J.M., Hoeks, A.P., Non-invasive ultrasound in arterial wall dynamics in humans: what have we learned and what remains to be solved. Eur Heart J 26 (2005), 960–966.
34. [34] Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Bohm, M., et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens 31 (2013), 1281–1357.
35. [35] De Korte, C.L., Fekkes, S., Nederveen, A.J., Manniesing, R., Hansen, H.H., Review: mechanical characterization of carotid arteries and atherosclerotic plaques. IEEE Trans Ultrason Ferroelectr Freq Control, 2016 May 26 [Epub ahead of print].
36. [36] Humphrey, J.D., Harrison, D.G., Figueroa, C.A., Lacolley, P., Laurent, S., Central artery stiffness in hypertension and aging: a problem with cause and consequence. Circulation Res 118 (2016), 379–381.
37. [37] Kaess, B.M., Rong, J., Larson, M.G., Hamburg, N.M., Vita, J.A., Levy, D., et al. Aortic stiffness, blood pressure progression, and incident hypertension. JAMA 308 (2012), 875–881.
38. [38] Spronck, B., Heusinkveld, M.H., Donders, W.P., de Lepper, A.G., Op't Roodt, J., Kroon, A.A., et al. A constitutive modeling interpretation of the relationship among carotid artery stiffness, blood pressure, and age in hypertensive subjects. Am J Physiology Heart Circulatory Physiology 308 (2015), H568–H582.
39. [39] Holtackers, R.J., Spronck, B., Heusinkveld, M.H., Crombag, G., Op t'Roodt, J., Delhaas, T., et al. Head orientation should be considered in ultrasound studies on carotid artery distensibility. J Hypertens 34 (2016), 1551–1555.
40. [40] Engelen, L., Bossuyt, J., Ferreira, I., van Bortel, L.M., Reesink, K.D., Segers, P., et al. Reference values for local arterial stiffness. Part A: carotid artery. J Hypertens 33 (2015), 1981–1996.
41. [41] Engelen, L., Stehouwer, C.D., Schalkwijk, C.G., Current therapeutic interventions in the glycation pathway: evidence from clinical studies. Diabetes Obes Metab 15 (2013), 677–689.
42. [42] Vlachopoulos, C., Xaplanteris, P., Aboyans, V., Brodmann, M., Cifkova, R., Cosentino, F., et al. The role of vascular biomarkers for primary and secondary prevention. A position paper from the European Society of Cardiology Working Group on peripheral circulation: Endorsed by the Association for Research into Arterial Structure and Physiology (ARTERY) Society. Atherosclerosis 241 (2015), 507–532.
43. [43] Charakida, M., Jones, A., Falaschetti, E., Khan, T., Finer, N., Sattar, N., et al. Childhood obesity and vascular phenotypes: a population study. J Am Coll Cardiol 60 (2012), 2643–2650.
44. [44] Ferreira, I., Beijers, H.J., Schouten, F., Smulders, Y.M., Twisk, J.W., Stehouwer, C.D., Clustering of metabolic syndrome traits is associated with maladaptive carotid remodeling and stiffening: a 6-year longitudinal study. Hypertension 60 (2012), 542–549.
45. [45] Katsiki, N., Athyros, V.G., Karagiannis, A., Mikhailidis, D.P., Metabolic syndrome and non-cardiac vascular diseases: an update from human studies. Curr Pharm Des 20 (2014), 4944–4952.
46. [46] Smulyan, H., Lieber, A., Safar, M.E., Hypertension, diabetes type II, and their association: role of arterial stiffness. Am J Hypertens 29 (2016), 5–13.
47. [47] Cecelja, M., Chowienczyk, P., Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review. Hypertension 54 (2009), 1328–1336.
48. [48] Reference-Values-Collaboration. Determinants of pulse wave velocity in healthy people and in the presence of cardiovascular risk factors: ‘establishing normal and reference values’. Eur Heart J 31 (2010), 2338–2350.
49. [49] Smulyan, H., Mookherjee, S., Safar, M.E., The two faces of hypertension: role of aortic stiffness. J Am Soc Hypertens 10 (2016), 175–183.
50. [50] Nilsson, P.M., Boutouyrie, P., Cunha, P., Kotsis, V., Narkiewicz, K., Parati, G., et al. Early vascular ageing in translation: from laboratory investigations to clinical applications in cardiovascular prevention. J Hypertens 31 (2013), 1517–1526.
51. [51] Heier, M., Margeirsdottir, H.D., Torjesen, P.A., Seljeflot, I., Stensaeth, K.H., Gaarder, M., et al. The advanced glycation end product methylglyoxal-derived hydroimidazolone-1 and early signs of atherosclerosis in childhood diabetes. Diabetes & Vasc Dis Res 12 (2015), 139–145.
52. [52] Hofmann, B., Adam, A.C., Jacobs, K., Riemer, M., Erbs, C., Bushnaq, H., et al. Advanced glycation end product associated skin autofluorescence: a mirror of vascular function?. Exp Gerontol 48 (2013), 38–44.
53. [53] Lund, T., Svindland, A., Pepaj, M., Jensen, A.B., Berg, J.P., Kilhovd, B., et al. Fibrin(ogen) may be an important target for methylglyoxal-derived AGE modification in elastic arteries of humans. Diabetes & Vasc Dis Res 8 (2011), 284–294.
54. [54] Zieman, S.J., Kamineni, A., Ix, J.H., Barzilay, J., Djousse, L., Kizer, J.R., et al. Hemoglobin A1c and arterial and ventricular stiffness in older adults. PloS One, 7, 2012, e47941.
55. [55] Wang, H., Weihrauch, D., Kersten, J.R., Toth, J.M., Passerini, A.G., Rajamani, A., et al. Alagebrium inhibits neointimal hyperplasia and restores distributions of wall shear stress by reducing downstream vascular resistance in obese and diabetic rats. Am J Physiology Heart Circulatory Physiology 309 (2015), H1130–H1140.
56. [56] Cangemi, C., Skov, V., Poulsen, M.K., Funder, J., Twal, W.O., Gall, M.A., et al. Fibulin-1 is a marker for arterial extracellular matrix alterations in type 2 diabetes. Clin Chem 57 (2011), 1556–1565.
57. [57] Seifert, M.E., de las Fuentes, L., Rothstein, M., Dietzen, D.J., Bierhals, A.J., Cheng, S.C., et al. Effects of phosphate binder therapy on vascular stiffness in early-stage chronic kidney disease. Am J Nephrol 38 (2013), 158–167.
58. [58] Vossen, L.M., Schurgers, L.J., van Varik, B.J., Kietselaer, B.L., Vermeer, C., Meeder, J.G., et al. Menaquinone-7 supplementation to reduce vascular calcification in patients with coronary artery disease: rationale and study protocol (VitaK-CAC Trial). Nutrients 7 (2015), 8905–8915.
59. [59] Wagenseil, J.E., Mecham, R.P., Elastin in large artery stiffness and hypertension. J Cardiovasc Transl Res 5 (2012), 264–273.
60. [60] Aggoun, Y., Farpour-Lambert, N.J., Marchand, L.M., Golay, E., Maggio, A.B., Beghetti, M., Impaired endothelial and smooth muscle functions and arterial stiffness appear before puberty in obese children and are associated with elevated ambulatory blood pressure. Eur Heart J 29 (2008), 792–799.
61. [61] Alexander, M.R., Owens, G.K., Epigenetic control of smooth muscle cell differentiation and phenotypic switching in vascular development and disease. Annu Rev Physiol 74 (2012), 13–40.
62. [62] Christen, A.I., Armentano, R.L., Miranda, A., Graf, S., Santana, D.B., Zocalo, Y., et al. Arterial wall structure and dynamics in type 2 diabetes mellitus methodological aspects and pathophysiological findings. Curr Diabetes Rev 6 (2010), 367–377.
63. [63] Kapustin, A.N., Davies, J.D., Reynolds, J.L., McNair, R., Jones, G.T., Sidibe, A., et al. Calcium regulates key components of vascular smooth muscle cell-derived matrix vesicles to enhance mineralization. Circulation Res 109 (2011), e1–12.
64. [64] Sehgel, N.L., Vatner, S.F., Meininger, G.A., “Smooth muscle cell stiffness syndrome”-revisiting the structural basis of arterial stiffness. Front Physiology, 6, 2015, 335.
65. [65] Agabiti-Rosei, E., Porteri, E., Rizzoni, D., Arterial stiffness, hypertension, and rational use of nebivolol. Vasc Health Risk Manag 5 (2009), 353–360.
66. [66] Gambillara, V., Thacher, T., Silacci, P., Stergiopulos, N., Effects of reduced cyclic stretch on vascular smooth muscle cell function of pig carotids perfused ex vivo. Am J Hypertens 21 (2008), 425–431.
67. [67] Den Ruijter, H.M., Peters, S.A., Anderson, T.J., Britton, A.R., Dekker, J.M., Eijkemans, M.J., et al. Common carotid intima-media thickness measurements in cardiovascular risk prediction: a meta-analysis. JAMA 308 (2012), 796–803.
68. [68] Hayashi, K., Naiki, T., Adaptation and remodeling of vascular wall; biomechanical response to hypertension. J Mech Behav Biomed Mater 2 (2009), 3–19.
69. [69] Chronic Kidney Disease Prognosis C, Matsushita, K., van der Velde, M., Astor, B.C., Woodward, M., Levey, A.S., et al. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 375 (2010), 2073–2081.
70. [70] Miyata, T., de Strihou, C., Diabetic nephropathy: a disorder of oxygen metabolism?. Nat Rev Nephrol 6 (2010), 83–95.
71. [71] Krumme, B., Renal Doppler sonography–update in clinical nephrology. Nephron Clin Pract, 103, 2006 c24–8.
72. [72] Nosadini, R., Velussi, M., Brocco, E., Abaterusso, C., Carraro, A., Piarulli, F., et al. Increased renal arterial resistance predicts the course of renal function in type 2 diabetes with microalbuminuria. Diabetes 55 (2006), 234–239.
73. [73] Toledo, C., Thomas, G., Schold, J.D., Arrigain, S., Gornik, H.L., Nally, J.V., et al. Renal resistive index and mortality in chronic kidney disease. Hypertension 66 (2015), 382–388.
74. [74] Ponte, B., Pruijm, M., Ackermann, D., Vuistiner, P., Eisenberger, U., Guessous, I., et al. Reference values and factors associated with renal resistive index in a family-based population study. Hypertension 63 (2014), 136–142.
75. [75] O'Neill, W.C., Renal resistive index: a case of mistaken identity. Hypertension 64 (2014), 915–917.
76. [76] Bruno, R.M., Daghini, E., Landini, L., Versari, D., Salvati, A., Santini, E., et al. Dynamic evaluation of renal resistive index in normoalbuminuric patients with newly diagnosed hypertension or type 2 diabetes. Diabetologia 54 (2011), 2430–2439.
77. [77] Bruno, R.M., Salvati, A., Barzacchi, M., Raimo, K., Taddei, S., Ghiadoni, L., et al. Predictive value of dynamic renal resistive index (DRIN) for renal outcome in type 2 diabetes and essential hypertension: a prospective study. Cardiovasc Diabetol, 14, 2015, 63.
78. [78] Bruno, R.M., Rossi, L., Fabbrini, M., Duranti, E., Di Coscio, E., Maestri, M., et al. Renal vasodilating capacity and endothelial function are impaired in patients with obstructive sleep apnea syndrome and no traditional cardiovascular risk factors. J Hypertens 31 (2013), 1456–1464 discussion 64.
79. [79] Saad, A., Crane, J., Glockner, J.F., Herrmann, S.M., Friedman, H., Ebrahimi, B., et al. Human renovascular disease: estimating fractional tissue hypoxia to analyze blood oxygen level-dependent MR. Radiology 268 (2013), 770–778.
80. [80] Thelwall, P.E., Taylor, R., Marshall, S.M., Non-invasive investigation of kidney disease in type 1 diabetes by magnetic resonance imaging. Diabetologia 54 (2011), 2421–2429.
81. [81] Li, Z., Woollard, J.R., Wang, S., Korsmo, M.J., Ebrahimi, B., Grande, J.P., et al. Increased glomerular filtration ra in early metabolic syndrome is associated with renal adiposity and microvascular proliferation. Am J Physiol Ren Physiol 301 (2011), F1078–F1087.
82. [82] Macisaac, R.J., Ekinci, E.I., Jerums, G., Markers of and risk factors for the development and progression of diabetic kidney disease. Am J Kidney Dis 63 (2014), S39–S62.
83. [83] Bruno, R., Vitolo, E., Giannini, L., Taddei, S., Ghiadoni, L., Solini, A., [OP.7B.10] Effect of bariatric surgery on vascular and renal biomarkers in morbidly obese, normotensive, non-diabetic patients. J Hypertens 34:Suppl 2 (2016), e88–e89.
84. [84] Penno, G., Solini, A., Bonora, E., Fondelli, C., Orsi, E., Zerbini, G., et al. Clinical significance of nonalbuminuric renal impairment in type 2 diabetes. J Hypertens 29 (2011), 1802–1809.
85. [85] Thomas, M.C., Macisaac, R.J., Jerums, G., Weekes, A., Moran, J., Shaw, J.E., et al. Nonalbuminuric renal impairment in type 2 diabetic patients and in the general population (national evaluation of the frequency of renal impairment cO-existing with NIDDM [NEFRON] 11). Diabetes Care 32 (2009), 1497–1502.